Advanced search
Publication Cover
Emerging Microbes & Infections Volume 11, 2022 - Issue 1
Submit an article Journal homepage
1,740
Views
6
CrossRef citations to date
0
Altmetric
Tuberculosis

Adjunctive Zoledronate + IL-2 administrations enhance anti-tuberculosis Vγ2Vδ2 T-effector populations, and improve treatment outcome of multidrug-resistant tuberculosis1

Hongbo Shena Shanghai Clinical Research Center for Infectious Disease (tuberculosis), Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Institute for Advanced Study, Tongji University School of Medicine, Shanghai, People’s Republic of ChinaCorrespondence[email protected]
View further author information
,
Enzhuo Yanga Shanghai Clinical Research Center for Infectious Disease (tuberculosis), Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Institute for Advanced Study, Tongji University School of Medicine, Shanghai, People’s Republic of China;b Department of Microbiology & Immunology and Center for Primate Biomedical Research, University of Illinois College of Medicine, Chicago, IL, USAView further author information
,
Ming Guoc State Key Laboratory of Virology, Modern Virology Research Center, College of Life Sciences, Wuhan University, Wuhan, People’s Republic of ChinaView further author information
,
Rui Yanga Shanghai Clinical Research Center for Infectious Disease (tuberculosis), Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Institute for Advanced Study, Tongji University School of Medicine, Shanghai, People’s Republic of ChinaView further author information
,
Guixian Huanga Shanghai Clinical Research Center for Infectious Disease (tuberculosis), Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Institute for Advanced Study, Tongji University School of Medicine, Shanghai, People’s Republic of ChinaView further author information
,
Ying Penga Shanghai Clinical Research Center for Infectious Disease (tuberculosis), Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Institute for Advanced Study, Tongji University School of Medicine, Shanghai, People’s Republic of ChinaView further author information
,
Wei Shaa Shanghai Clinical Research Center for Infectious Disease (tuberculosis), Shanghai Institute of Infectious Disease and Biosecurity, Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Institute for Advanced Study, Tongji University School of Medicine, Shanghai, People’s Republic of ChinaCorrespondence[email protected]
View further author information
,
Feifei Wangd Department of Medical Microbiology and Parasitology, Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), Shanghai Institute of Infectious Disease and Biosecurity, School of Basic Medical Sciences, Shanghai Medical College, Fudan University, Shanghai, People’s Republic of ChinaCorrespondence[email protected]
View further author information
&
Ling Shenb Department of Microbiology & Immunology and Center for Primate Biomedical Research, University of Illinois College of Medicine, Chicago, IL, USACorrespondence[email protected]
View further author information
 show all
Pages 1790-1805 | Received 18 Mar 2022, Accepted 24 Jun 2022, Published online: 21 Jul 2022

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.